Alkem Laboratories Limited (hereinafter referred to as “we”, “our”, or “us”) is one of the leading entities in the Indian pharmaceutical industry. With a presence spanning over five decades, we have enriched the industry through pioneering work aimed at making a significant impact on people’s lives. Our dedication and perseverance are further exemplified by our position among the top five companies in the Indian Pharmaceutical Market (IPM).
Our journey towards attaining leadership in the pharmaceutical industry is a testament to our legacy of hard work, perseverance, and determination to make a difference. Pioneering research, innovation, and strict adherence to quality standards have set us apart and form the core of our organizational strategy. With a focus on accessibility and affordability, we manufacture and market pharmaceutical products across all major therapeutic segments.
Our expansive global presence across 40+ countries underscore our commitment to extending quality healthcare solutions worldwide. Our dedication is manifested in our 19 state-of-the-art manufacturing facilities and cutting-edge Research and Development (R&D) centers across India and the United States, empowering us to deliver top-tier pharmaceutical products.
Our Values are at the heart of who we are and how we act
For our words and actions and their consequences
In our relationships with our fellow employees and the communities affected by our business
To fellow employees, shareholders, customers and suppliers through adherence to all applicable laws, regulations & policies, transparency & a high standard of behavior
In communicating within the Company & with our suppliers, customers & all stakeholders, while at the same time protecting the Company’s confidential information & trade secrets
For fellow employees, shareholders, customers and suppliers while showing willingness to elicit, listen and to take into account their opinions and value their feedback
In our products & services, by striving to provide defect-free products and services to our customers
Of thinking and behavior to meet the ever-changing conditions, taking care to act in harmony with nature to ensure progress and success in all endeavors
Of highest grade in product manufacturing and workplace environment
For all the benefits received, confident that this attitude will be a source of unbounded joy and vitality, enabling us to overcome any obstacles we may encounter
Operating across diverse business segments mitigates concentration risk and allows us to adeptly meet dynamic customer demands. Our portfolio spans branded generics, generic drugs, active pharmaceutical ingredients, nutraceuticals, and biosimilars, driving growth through focused excellence.
Our R&D infrastructure is integral to our sustained innovation and long-term success, encompassing R&D centers and teams dedicated to developing generics, biosimilars, transdermal drug delivery systems, oral films, and Novel Drug Delivery Systems (NDDS). To bolster our capabilities, we consistently invest in our R&D, with ₹ 5,229 million allocated on a consolidated basis to the pipeline in FY 2023-24.
Our portfolio comprises
Our foray into the world-wide pharmaceutical market is strengthened by our national as well as international presence. The United Stated (US) is our second-largest market, after India. We also have presence spread across Australia, LatAm, and Europe.
Employees
Manufacturing Facilities
MANUFACTURING FACILITIES
R&D FACILITIES
Besides being the fifth-largest player in the domestic market, we hold a strong position in the international territories where we operate through subsidiaries and parent company. The contribution of international sales in total sales stood at 32.2%.
Sales growth in US business
Sales growth in non-US business
cumulative Abbreviated New Drug Application (ANDA) filings with the US FDA
Cumulative ANDA approvals from the US FDA
Filings across various international markets
US FDA approved facilities in India and US
We hold a prominent position in acute therapy areas like Anti-infective, Gastro-intestinal, Pain Management, and Vitamins/Minerals/Nutrients. Our product lineup boasts well-known brands including Clavam, Pan, Pan-D, and Taxim-O, all ranked among India’s top 50 pharmaceutical brands. In the anti-infective sector, we have maintained leadership for over a decade, and we are also a key player in the Indian trade generic market. Additionally, we are steadily expanding our footprint in chronic therapy domains like Neuro/CNS, Cardiac, Anti-diabetes, and Dermatology.
in Anti-Infective
in Vitamins/Minerals/Nutrients Segment
in Gastrointestinal, Pain/Analgesics Segment
stockists
medical representatives (Excluding Managers & including Indchemie and Cachet)
Sales depots and CFAs
Growth registered by Anti-diabetic business segment
Featured amongst the top 50 pharmaceutical brands in India
Drive the robust performance in domestic business
* As per IQVIA MAT March 2023 data
Menu
